HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PMI-5011

an ethanolic extract of Artemisia dracunculus that is hypoglycemic in animal models for Type 2 diabetes and contains at least 6 bioactive compounds responsible for its anti-diabetic properties
Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ribnicky, David M: 4 articles (07/2015 - 03/2009)
2. Stavniichuk, Roman: 2 articles (03/2011 - 01/2010)
3. Watcho, Pierre: 2 articles (03/2011 - 01/2010)
4. Obrosova, Irina G: 2 articles (03/2011 - 01/2010)
5. Cefalu, William T: 2 articles (01/2011 - 03/2009)
6. Zuberi, Aamir: 2 articles (01/2011 - 03/2009)
7. Raskin, Ilya: 2 articles (01/2010 - 03/2009)
8. Shailendra, Giri: 1 article (07/2015)
9. Aggarwal, Sita: 1 article (07/2015)
10. Karki, Namrata: 1 article (07/2015)

Related Diseases

1. Peripheral Nervous System Diseases (PNS Diseases)
2. Prediabetic State (Prediabetes)
3. Obesity
4. Body Weight (Weight, Body)
5. Inflammation

Related Drugs and Biologics

1. Insulin (Novolin)
2. Leptin
3. Streptozocin (Streptozotocin)
4. Sorbitol (Yal)
5. Luciferases
6. Dietary Fats (Ghee)
7. Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)
8. orexins (orexin)
9. melanin-concentrating hormone (melanin concentrating hormone)